Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pulmonary aspergillosis.

George R Thompson1, Thomas F Patterson

  • 1Division of Infectious Diseases, Department of Medicine, University of Texas Health Science Center at San Antonio, San Antonio, Texas 78229, USA.

Seminars in Respiratory and Critical Care Medicine
|March 28, 2008
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Anti-infective therapy and novel treatment options for coccidioidomycosis.

Expert review of anti-infective therapy·2026
Same author

Sustained Reduction in Cardiopulmonary Fitness in Long COVID: A Report from the RECOVER-adult Cohort Study.

JACC. Advances·2026
Same author

Erratum for Wiederhold et al., "The next-generation polyene EL219 is efficacious in an experimental model of central nervous system coccidioidomycosis caused by <i>Coccidioides immitis</i>".

Antimicrobial agents and chemotherapy·2026
Same author

Exhausted T cell phenotypes in disseminated coccidioidomycosis.

JCI insight·2026
Same author

Frequency and Duration of Diagnostic Delays Associated with Coccidioidomycosis and Risk Factors for Missed Diagnoses, United States.

Emerging infectious diseases·2026
Same author

<i>Pneumocystis jirovecii</i> Pneumonia in Non-HIV, Non-HCT Adults: Real-World Patterns of Overlapping Immunosuppression and PJP-Active Therapy.

The Annals of pharmacotherapy·2026
Same journal

Monographic Issue on New Concepts in Acute Exacerbations of COPD.

Seminars in respiratory and critical care medicine·2026
Same journal

Bidirectional Clinical Interactions among Exacerbations and Comorbidities in COPD: A Narrative Review.

Seminars in respiratory and critical care medicine·2026
Same journal

Radiological Approach to Severe Respiratory Infections and Pulmonary Complications in Immunocompromised Patients.

Seminars in respiratory and critical care medicine·2026
Same journal

Two Sides of the Same Smoke: Decoding Respiratory Bronchiolitis-Associated Interstitial Lung Disease and Alveolar Macrophage Pneumonia.

Seminars in respiratory and critical care medicine·2026
Same journal

Role of Vaccination in the Prevention of ECOPD.

Seminars in respiratory and critical care medicine·2026
Same journal

Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Pharmacological Treatment of AECOPD New Perspectives.

Seminars in respiratory and critical care medicine·2026
See all related articles

Pulmonary aspergillosis is increasing in immunocompromised patients, including those with prolonged neutropenia and HIV/AIDS. Effective antifungal therapy requires understanding the full spectrum of Aspergillus-related disease, as diagnosis remains challenging.

Area of Science:

  • Medical Mycology
  • Infectious Diseases
  • Pulmonology

Background:

  • Rising incidence of pulmonary aspergillosis in immunocompromised patient populations.
  • Increasing numbers of patients undergoing hematopoietic stem cell or lung transplantation.
  • Growing prevalence of human immunodeficiency virus (HIV) and acquired immunodeficiency syndrome (AIDS).

Purpose of the Study:

  • To highlight the increasing challenge of pulmonary aspergillosis.
  • To emphasize the need for appropriate antifungal therapy selection and duration.
  • To address diagnostic difficulties in identifying Aspergillus infections.

Main Methods:

  • Review of current literature on pulmonary aspergillosis.
  • Analysis of the spectrum of disease caused by Aspergillus species.

Related Experiment Videos

  • Evaluation of the role of emerging antifungal agents.

    • Main Results:

    • Pulmonary aspergillosis incidence is rising due to expanding at-risk populations.
    • Aspergillus infections present a wide spectrum, from colonization to disseminated disease.
    • Antifungal agent efficacy depends on understanding the full disease spectrum.

    Conclusions:

    • Pulmonary aspergillosis poses a significant and growing threat.
    • Appropriate and timely antifungal treatment is crucial for patient outcomes.
    • Diagnostic limitations necessitate improved sensitivity and specificity of testing methods.